Article
Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings
2021-02-23
Abstract excerpt
<h4>Background: </h4> Data on the modalities of disclosing genomic secondary findings (SFs) remain scarce. We explore cancer patients’ and the general public’s perspectives about disclosing genomic SFs and the modalities of such disclosure. <h4>Methods: </h4> Sixty-one cancer patients (n=29) and members of the public (n=32) participated in eight focus groups in Montreal and Quebec City, Canada. They were asked to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 226622cb-9e71-5c33-beea-8622b9d99902
- DOI
- 10.21203/rs.3.rs-220910/v1
